Dominari Holdings Inc.

DOMH

US0088753043

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:00:00 23/05/2024 am IST			5-day change	1st Jan Change
2.22 ^USD	+3.74%		+6.22%	-14.29%

09/05	Dominari Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04/04	North American Morning Briefing : Focus Turns to -2-	DJ

AIkido Pharma Inc. announces an Equity Buyback for $2 million worth of its shares.

December 06, 2022 at 08:15 pm IST

AIkido Pharma Inc. (NasdaqCM:AIKI) announces a share repurchase program. Under the program, then company will repurchase up to $2 million worth of its outstanding common shares.

Latest news about Dominari Holdings Inc.

Dominari Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
North American Morning Briefing : Focus Turns to -2-	04/04	DJ
Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
North American Morning Briefing : Stocks Set for -2-	28/03	DJ
Dominari Holdings Inc. Announces Appointment of Mr. Kyle Wool as President	19/12	CI
Dominari Holdings Inc. Announces Board Changes	13/11	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	07/11	CI
Dominari Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11	CI
Dominari Holdings Inc. Announces Executive Changes	01/23/01	CI
Dominari Holdings Inc. Announces Resignation of Paul Lemire as Member of the Board of Directors and Member of Audit Committee, Compensation Committee, and Nominating Committee	10/23/10	CI
Dominari Holdings Inc. Announces Management Changes	23/23/23	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	10/23/10	CI
Dominari Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
Dominari Holdings Inc. Appoints Kyle Wool as CEO of Dominari Securities LLC	24/23/24	CI
North American Morning Briefing : Powell on Tap -2-	19/23/19	DJ
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	11/23/11	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on January 24, 2022.	11/23/11	CI
Dominari Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
Dominari Holdings Inc. Appoints Matthew B. McCullough as the General Counsel	06/23/06	CI
Dominari Holdings Unit Acquires Broker Team With $700 Million in Assets Under Management	18/23/18	MT
Dominari Holdings Names George Way Chief Financial Officer	03/23/03	MT
Dominari Holdings Inc. Appoints George Way as Chief Financial Officer	03/23/03	CI
Tranche Update on Dominari Holdings Inc.'s Equity Buyback Plan announced on December 6, 2022.	01/23/01	CI
Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
North American Morning Briefing : Traders Await -3-	31/23/31	DJ

Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securitiesâ investment banking division provides strategic advisory services and capital markets products to middle market businesses.

Sector

Biotechnology & Medical Research

More about the company

	1st Jan change	Capi.
DOMINARI HOLDINGS INC.	-14.29%	12.7M
MODERNA, INC.	+64.23%	55.07B
IQVIA HOLDINGS INC.	-2.31%	41.79B
LONZA GROUP AG	+44.36%	40.22B
CELLTRION, INC.	-8.29%	28.17B
ICON PUBLIC LIMITED COMPANY	+11.97%	26.28B
ALNYLAM PHARMACEUTICALS, INC.	-21.16%	18.93B
BIO-TECHNE CORPORATION	+7.54%	13.03B
MEDPACE HOLDINGS, INC.	+27.17%	12.26B
UNITED THERAPEUTICS CORPORATION	+25.72%	12.21B

Other Biotechnology & Medical Research

Dominari Holdings Inc.

Equities

DOMH

US0088753043

Biotechnology & Medical Research

AIkido Pharma Inc. announces an Equity Buyback for $2 million worth of its shares.

Latest news about Dominari Holdings Inc.

Chart Dominari Holdings Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research